First-in-Human Total-Body PET/CT Imaging Using89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
Year: 2024
Type: article
Study design: Case Report
Abstract: We report on a 54-y-old man with stage pT3pN1pM1(HEP) pancreatic-head adenocarcinoma and liver metastasis. After diagnosis 20 mo previously, he underwent Whipple surgery and multiple chemotherapy regimens including folinic acid, fluorouracil, irinotecan hydrochloride, and oxaliplatin; gemcitabine/
Source: Journal of Nuclear Medicine
Authors: Harshad R. Kulkarni, Kevin A. Maupin, Tina Brennan, Jens Forsberg, Dan Rogers, Mark Olson, Brandon R. Mancini, Anthony Chang, Sreenivasa R. Chandana, Ryohei Kobayashi
Institutions: Michigan State University, Nihon Medi-Physics (Japan)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402269367